Close

Response to Notice 227 Patents Amendment Bill, 2004

Feb 5 2004

Letter regarding the Conference of the Parties of the Convention on Biological Diversity

Feb 5 2004

BIO/BayBIO/BIOCOMM

Feb 4 2004

Letter to California Fish and Game Commission: regarding a decision not to exempt transgenic ornamental fish from the restricted species list (Feb. 4, 2004).

BIO/BayBIO/BIOCOMM

Feb 4 2004
Letter to California Fish and Game Commission: regarding a decision not to exempt transgenic ornamental fish from the restricted species list.

BIO Comments on Pharmacogenomic Data Submissions

Feb 2 2004
BIO commends FDA for recognizing the significance of the emerging science of pharmacogenomics and the importance of appropriate consideration and use of pharmacogenomic data by the agency.

Comments regarding Pharmacogenomic Data Submissions

Feb 2 2004

BIO letter supporting the goals of H.R. 2391, the Cooperative Research and Technology Enhancement (CREATE) Act

Jan 21 2004

BIO Comments on FDA's draft Guidance for Reviewers

Dec 22 2003

On Providing Regulatory Submissions in Electronic Format - General Considerations.

Letter, Hon. Robert Zoellick, U.S. Trade Representative, in support of CAFTA

Dec 10 2003

Letter from 30 Congressmembers urging Chairman Manzullo and Chairwoman Snowe to include a correction in SBA Reauthorization legislation (S. 1375/HR 2802)

Dec 10 2003